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0163-4453/ª 2017 The Author(s). Pub
under the CC BY license (http://creaSummary Background: Improved diagnostics for typhoid are needed; a typhoid controlled
human infection model may accelerate their development and translation. Here, we evaluated
a blood culture-PCR assay for detecting infection after controlled human infection with S. Ty-
phi and compared test performance with optimally performed blood cultures.
Methodology/Principal findings: Culture-PCR amplification of blood samples was performed
alongside daily blood culture in 41 participants undergoing typhoid challenge. Study endpoints
for typhoid diagnosis (TD) were fever and/or bacteraemia. Overall, 24/41 (59%) participants
reached TD, of whom 21/24 (86%) had 1 positive blood culture (53/674, 7.9% of all cultures)
or 18/24 (75%) had 1 positive culture-PCR assay result (57/684, 8.3%). A further five non-
bacteraemic participants produced culture-PCR amplicons indicating infection; overall sensi-
tivity/specificity of the assay compared to the study endpoints were 70%/65%. We found no sig-
nificant difference between blood culture and culture-PCR methods in ability to identify cases
(12 mismatching pairs, p Z 0.77, binomial test). Clinical and stool culture metadata demon-
strated that additional culture-PCR amplification positive individuals likely represented trueine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of
dom.
ediatrics.ox.ac.uk (T.C. Darton).
.01.006
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tivecommons.org/licenses/by/4.0/).
Culture-PCR assay for typhoid 359cases missed by blood culture, suggesting the overall attack rate may be 30/41 (73%) rather
than 24/41 (59%). Several participants had positive culture-PCR results soon after ingesting
challenge providing new evidence for occurrence of an early primary bacteraemia.
Conclusions/Significance: Overall the culture-PCR assay performed well, identifying extra
typhoid cases compared with routine blood culture alone. Despite limitations to widespread
field-use, the benefits of increased diagnostic yield, reduced blood volume and faster turn-
around-time, suggest that this assay could enhance laboratory typhoid diagnostics in research
applications and high-incidence settings.
ª 2017 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).Introduction
Typhoid fever, a non-specific febrile illness caused by
infection with Salmonella enterica serovar Typhi (S. Typhi),
is common in tropical regions.1 A key limitation to
improving the control of typhoid fever is the lack of reliable
diagnostic tests.2,3 In addition to confirming infection in in-
dividuals, accurate laboratory diagnostics are needed to
ascertain true disease burden, to improve understanding
of the natural history of infection in humans, and to eval-
uate vaccine efficacy.1,2,4
Diagnostic approaches for typhoid infection are broadly
aimed either at directly detecting bacteria or bacterial
products or measuring the host response in clinical sam-
ples.2,4,5 Blood culture remains the diagnostic technique of
choice, but only identifies 45e70% of confirmed cases, even
with the availability of newer continuous automated cul-
ture systems.5e7 Serological tests including the Widal test
are widely available in endemic settings, although in the
absence of paired clinical samples or background popula-
tion serosurveillance data these tests perform poorly with
low sensitivity and specificity.5,8
Given the poor accuracy of currently available diag-
nostic tests, attempts have been made to develop PCR-
based assays to detect bacterial DNA.9e13 Few, if any, of
these approaches have been instituted in clinical settings
mainly due to the difficulty of validating tests when using
‘real-life’ specimens, in which only few, mostly intracel-
lular bacteria (median, 0.5 CFU/mL blood) are present.2,14
One method to increase the sensitivity of S. Typhi detection
from blood is to use ox-bile as a selective culture me-
dia.15,16 Ox-bile reduces both coagulation and serum com-
plement killing activity and causes the selective lysis of
human rather than Salmonella cells.17,18 Recently, we
developed a culture-PCR assay incorporating a brief pre-
incubation in ox-bile along with PCR amplification of the
S. Typhi flagellin gene, fliC.19,20 Here, we have evaluated
this culture-PCR assay as a diagnostic for detecting S. Typhi
in the blood of healthy adult volunteers developing typhoid
while participating in a human challenge model.21
Methods
Participants and challenge
Challenge of healthy adults with a single oral dose of a wild-
type S. Typhi Quailes strain was performed in a dose-escalation study, as previously described.4,21 Briefly,
healthy consenting adult volunteers aged between 18 and
60 years were challenged by ingesting a fresh preparation
of 103 or 104 CFU of S. Typhi suspended in sodium bicarbon-
ate solution. After challenge, participants were reviewed
daily for symptoms and signs of typhoid fever and clinical
samples were collected (Table 1). If the study endpoint of
typhoid diagnosis (TD) was reached, additional samples
were collected and antimicrobial treatment was initiated.
All remaining participants were given antimicrobial treat-
ment on day 14. TD criteria were clinical (temperature
38 C sustained for 12 h) and/or microbiological (positive
blood culture).
Diagnostic blood culture (reference standard)
Blood for culture was collected daily for 14 days or up to
96 h after TD, whichever was the later, and processed
according to national standard methods as previously
described.21,22 At all time points after challenge 10 mL
blood was collected, except at TD when this was reduced
to 5 mL (Table 1). Stool culture was performed as previously
described.21 Bacterial isolates were identified by pheno-
typic, biochemical and serological testing according the
Kauffmann-White classification, following standard
methods.23,24
Culture-PCR assay
To perform the culture-PCR assay, 5 mL of heparinised
peripheral venous blood was collected at daily after
challenge (Table 1), and performed as previously
described.19,20,25 Briefly, blood was added to culture media
(20 mL 3% (w/v) ox bile/tryptone soya broth containing
1.5 mL micrococcal nuclease) and incubated for 5 h
(37 C, 220 rpm New Brunswick, Excella e24). Bacteria
were then concentrated by centrifugation at 6000 g for
20 min and the supernatant removed. DNA was extracted
from the bacterial pellet using UltraClean BloodSpin
kits following the manufacturer’s instructions, except that
elution of the final DNA was performed using 50 mL of pre-
heated ‘Buffer 5’ (65 C for 5 min) prior to centrifugation.
PCR amplification was performed with primers targeting
the S. Typhi flagellin gene, fliC-d (GenBank L21912,26) as
described by Levy et al.10
Amplification reactions were performed in 50 mL volumes
containing 10 mL DNA template and 0.2 mM each of H-for and
Table 1 Assay schedule and associated blood volumes for laboratory diagnostic tests performed during the study. A) Assays
performed in all participants, and B), assays performed in participants reaching clinical or microbiological TD endpoint. Chal-
lenge: oral ingestion of 103 or 104 CFU S. Typhi Quailes strain suspended in 30 mL/0.53 g NaHCO3(aq). Antimicrobials: first-line,
ciprofloxacin 500 mg twice daily for 14 days.
A) All participants
Day 0 0 0 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 28
Hour 0 6 12 0 12 e e e e e e e e e e e e e e
Procedure Challenge Antimicrobials
started
Antimicrobials
completed
Blood culture e 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 e
Culture-PCR e 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5
B) Additional time points in typhoid-diagnosed participants
Timepoint þ hours TD þ 0 TD þ 6 TD þ 12 TD þ 24 TD þ 36 TD þ 48 TD þ 72 TD þ 96
Procedure Antimicrobials started
Blood culture 5 10 10 10 10 10 10 10
Culture-PCR 5 5 5 5 5 5 5 5
360 T.C. Darton et al.Hd-rev primers (TopTaq PCR Master Mix Kit, Qiagen). Where
required, distilled H2O and/or non-study DNA extracted
from healthy donor blood was used as negative controls;
genomic DNA extracted from S. Typhi Quailes strain culture
was used as a positive control template. DNA amplification
was performed using standard thermocycler equipment at:
95 C for 5 min followed by 35 cycles of 93 C for 30 s,
55 C/30 s, and 72 C/40 s and terminating with 1 cycle
of 72 C for 5 min. The specific target PCR amplicons could
be observed at 763 bp when separated by 1% (w/v)
ethidium bromide agarose gel electrophoresis and visual-
ized using UV light transillumination. Amplicons were cate-
gorised as either being present (positive) or absent
(negative) by visualisation with the naked eye.
Blood inoculation experiments and detection limits
Prior to the investigation of clinical specimens, assay
performance and laboratory sensitivity was evaluated using
S. Typhi -negative whole blood (5 mL) containing known
concentrations of S. Typhi DNA, added after the incubation
step (Supplementary Fig. 1). The calculated sensitivity of
PCR amplification was at least 0.015 rg/mL, equivalent to
a DNA starting concentration of 30 bacteria per reaction
(each bacterium containing w5 fg DNA)27,28 or 6 CFU/
mL in the original starting blood volume, assuming no multi-
plication had taken place during incubation.
Reporting and statistical analysis
Data pertaining to the diagnostic accuracy of the PCR assay
in comparison with the predefined study endpoint of
typhoid diagnosis (TD) or positive blood culture are re-
ported according to the STARD criteria.29 The diagnostic ac-
curacy of PCR or blood culture in comparison to TD are
reported using sensitivity, specificity, positive and negative
likelihood ratios, positive and negative predictive values
and diagnostic odds ratio, each with a 95% confidence inter-
val. The statistical significance of the differences in sensi-
tivities of PCR and blood culture was assessed bydiscordant pairs analysis using a two-tailed binomial test.
Data were analysed using Prism v6.0e (GraphPad Software
Inc).
Ethics
The challenge study was approved by the National Research
Ethics Service (Oxfordshire Research Ethics Committee A,
10/H/0604/53) and was performed in accordance with the
principles of the ICH-Good Clinical Practice guidelines and
amendments. All study participants provided written
informed consent in accordance with the Declaration of
Helsinki. While all blood culture and PCR data were
generated prospectively during the study, only blood culture
results were used to make clinical management decisions.
Results
Performance of culture-PCR in a typhoid challenge
study
Using a dose-escalation approach to determine the optimal
challenge dose, 41 participants were challenged with either
103 or 104 CFU of S. Typhi Quailes strain, as previously
described.21 Attack rates were 55% and 65% for each
dose, respectively; the median day of illness onset was
seven days after challenge.
Overall, 684 serial samples were collected for culture-
PCR from 41 challenge participants, 24 of whom were
diagnosed with typhoid fever (TD). One individual was
treated before day 14 based on symptoms alone without
fulfilling the study TD criteria (included here in the nTD
group, Supplementary Table 1); the remaining 16 partici-
pants were treated with antimicrobials at day 14 but did
not develop infection, defined as not diagnosed with
typhoid (nTD, Table 2). From the 684 samples collected
57 (8.3%) were positive by culture-PCR assay, and were
collected from 23 study participants (Fig. 1). From three
days after challenge onwards, nTD and TD participants
Table 2 Number (%) of culture-PCR positive samples identified during the study according to challenge outcome and day/time
of sample collection. Samples from participants diagnosed with typhoid are further described by day relative to typhoid diag-
nosis (and antibiotic initiation) in 48-h blocks. nTD, non-typhoid diagnosed; TD, typhoid diagnosed.
Challenge outcome, n/N (%)
nTD (17 participants) TD (24 participants) ALL (41 participants)
Time point after challenge
Day 0 to Day 3 4/62 (6.5) 5/87 (5.7) 9/149 (6.0)
Day 3 onwards 11/203 (5.4) 37/332 (11.1) 48/535 (9.0)
Total 15/265 (5.7) 42/411 (10.2) 57/684 (8.3)
Time relative to TD
>72 h e 2/57 (3.5) e
72 to 24 h e 18/44 (40.9) e
24 to þ24 h e 15/39 (38.4) e
þ24 to þ72 h e 0/83 (0) e
>72 h e 2/71 (2.8) e
41 parƟcipants challenged
Culture-PCR
n=41
PCR posiƟve
n=23
BLOOD CULTURE
BC posiƟve
n=16
PCR negaƟve
n=18
BLOOD CULTURE
BC posiƟve
n=5
BC negaƟve
n=7
BC negaƟve
n=13
2 clinical dx
5 nTD
5 micro dx
11 clinical & micro dx 
5 micro dx 1 clinical dx
12 nTD
Figure 1 STARD flowchart describing culture-PCR results in comparison with the reference standard (Blood culture, BC) for
diagnosis of challenge study participants with typhoid infection after challenge. nTD, non-typhoid diagnosed; clinical dx, clinical
diagnosis; micro dx, microbiological diagnosis.
Culture-PCR assay for typhoid 361yielded 11/203 (5.4%) and 37/332 (11.1%) positive culture-
PCR assay results, respectively. After the initiation of anti-
microbials 6/24 (25%) TD participants generated nine
further positive culture-PCR assay results, of which 5/9
occurred within six hours of initiated antimicrobial treat-
ment (e.g. Fig. 2).
In comparison with the culture-PCR methods, blood
culture alone yielded 53/674 (7.9%) positive samples from
the 41 study participants. Positive PCR amplifications were
evident earlier in the challenge course than with culture,however the maximal day of blood culture and PCR positivity
was six days after challenge for both assays (Fig. 3).Early primary DNAaemia in typhoid challenge
participants
The earliest positive culture-PCR sample was collected only
six hours after challenge; a further two participants were
positive by 12 h. In total, nine positive samples from seven
Figure 2 Example of a challenge study participant who had several early positive culture-PCR results (yellow squares), in
addition to early positive stool culture result (orange squares). This participant was subsequently diagnosed with typhoid infec-
tion based on both microbiological and clinical criteria. Red square, positive blood culture; grey squares, no sample collected;
black line, oral temperature; dashed grey line, C-reactive protein level; shaded area, antibiotic treatment initiated.
362 T.C. Darton et al.participants were obtained 48 h after the ingestion of S.
Typhi with blood samples from a further two participants
testing positive within 72 h (Table 2 and Fig. 3). There
was no significant association between early stool shedding
and culture-PCR assay positivity (n Z 3/16, p Z 0.63,
Fisher’s exact test; Fig. 2). Similarly, an early positive
culture-PCR result was not predictive of subsequent devel-
opment of typhoid infection (diagnostic odds ratio (DOR)
0.57, 95%CI 0.12e2.71, p Z 0.69) or development of S. Ty-
phi bacteraemia (DOR 0.50, 95%CI 0.10e2.44, p Z 0.45).
Confirmation of typhoid diagnosis
Of the 24 participants diagnosed with typhoid infection,
21/24 (87.5%) had a bacteraemia with or without reaching
the clinical endpoint (Fig. 1, Supplementary Table 1).
While culture-PCR and blood culture results concurred in
participants with bacteraemia and fever, discrepancies
arose in participants diagnosed by positive blood culture
or temperature criteria alone. In three participants diag-
nosed by the clinical endpoint, 2/3 generated a positive
culture-PCR result supporting the clinical diagnosis while
all blood cultures remained negative throughout the chal-
lenge period (Fig. 1 and Supplementary Fig. 3). In addition,
the participant treated early based on symptoms alone
(i.e. no bacteraemia or fever) also had several positive
culture-PCR assay results after the start of antimicrobial
treatment.
In contrast, five participants had positive blood cultures
on at least one occasion but remained PCR amplification
negative throughout. In general, these five individuals had
fewer positive blood cultures than those who generated
positive blood cultures and were culture-PCR positive(mean, 2.00 vs. 2.73, respectively); this difference was
non-significant (95%CI, 0.75 to 2.22, p Z 0.31, T test).
Assuming that the predefined TD criteria were the best
reference standard, culture-PCR demonstrated a sensitivity
and specificity of 70 and 65%, respectively (Table 3).
Despite forming part of the TD definition, the use of blood
culture alone as a reference standard did not detect all
cases of typhoid: routine blood culture was more sensitive
and specific than culture-PCR; 87.5 and 100%, respectively.
Interestingly, addition of the culture-PCR results to the
study endpoint definitions suggested an overall attack
rate after challenge of 73% rather than 59%. Discordant
pairs analysis identified 12 mismatching culture-PCR and
blood culture results, and confirmed that there was no sig-
nificant difference in yield between culture-PCR and blood
culture sensitivity if either was used alone to diagnose
infection (pZ 0.77, binomial test; Supplementary Table 2).
Asymptomatic DNAaemia after typhoid challenge
In participants who remained nTD throughout the 14-day
observation period, 6/17 generated 1 positive culture-
PCR result (Fig. 1). Further investigation of participants’
clinical features demonstrated that several had features
indicative of the development of typhoid infection in this
controlled challenge scenario (Supplementary Table 3).
These features included a single elevated temperature
reading within 12 h of the positive culture-PCR result
(Supplementary Fig. 4), maximal symptom reporting on
the day of the positive culture-PCR result (Supplementary
Table 3) and the additional participant who was treated
based on symptoms without meeting the TD endpoint defi-
nition. The remaining 2/6 participants had only mild
Figure 3 Number of positive culture-PCR and blood culture samples collected after challenge by typhoid outcome. The 6 and
12 h positive results have been pooled into the 0.5 day group. The maximum number of TD samples/day exceeds the number of TD
participants as more than one sample was collected per day following initiation of antibiotic treatment. TD, typhoid diagnosed;
nTD, non-typhoid diagnosed; PCR, culture-PCR assay; BC, blood culture.
Culture-PCR assay for typhoid 363symptoms, reporting constipation and a cough on the day of
the positive result.
Discussion
Direct detection of pathogen nucleic acid is a widely-used
method to increase sensitivity, specificity and time-to-
result in modern diagnostic laboratories.30e32 We have pre-
viously described the first culture-PCR assay for detecting
S. Typhi in the modern era20; here, we demonstrate the
performance of this method, specifically designed to sensi-
tively detect the S. Typhi fliC-d gene in the blood of partic-
ipants undergoing typhoid challenge. While the direct
comparison with blood culture suggested that the sensi-
tivity of the assay was lower for participants reaching the
typhoid diagnosis study endpoints, overall, the culture-
PCR provided useful additional information compared with
blood culture alone. This additional approach enabled the
detection and confirmation of typhoid infection cases that
would have been missed by blood culture. In using a human
typhoid challenge model to perform the evaluation, we
have provided unique insights into the natural history of
typhoid infection. These include evidence for the fre-
quency of asymptomatic infection after exposure, and the
confirmation of bacterial DNA circulation in blood soon af-
ter exposure.The application of PCR-based laboratory methods to
confirm clinical diagnoses of typhoid fever are not
commonly reported, despite the appeal of detecting non-
cultivable bacteria. This is of special relevance in most
endemic settings, where antimicrobial pre-treatment or
immune interference are common and likely reduce culture
sensitivity still further. In this study we demonstrate a PCR
sensitivity of 70% using selective pre-incubation in ox-bile
of a 5 mL blood sample, compared with the study defined
endpoints. As reported previously, the median quantitative
bacterial loads at diagnosis are 0.47 and 1.10 CFU/mL in
participants ingesting the 103 or 104 CFU dose, respec-
tively.21 With our estimation of a lower detection limit of
6 CFU/mL, it is not surprising that the assay may have failed
to detect some cases. The extreme challenge posed by de-
tecting such a small number of bacteria has been recently
demonstrated in a field study evaluating a sensitive qPCR,
capable of detecting w1 CFU/mL, which, despite favour-
able performance in developmental stages demonstrated
field performance of 40% sensitivity and 91% specificity.33
While the detection of bacterial DNA may be increased
by pre-incubation of clinical material prior to performing
DNA extraction,27,34,35 disadvantages to this method
include loss of the ability to accurately quantify bacterial
numbers in the blood directly, prolongation of assay time
and the requirement for microbiological culture facilities.
Table 3 Contingency tables displaying estimates [95% CIs] of the sensitivity and specificity for culture-PCR and routine blood
culture for diagnosing participants with typhoid infection during a challenge study. *Note that bacteraemia was one of the diag-
nostic criteria. TD, typhoid diagnosed; nTD, non-typhoid diagnosed; LR, likelihood ratio; PPV, positive predictive value; NPV,
negative predictive value; DOR, diagnostic odds ratio.
Challenge outcome Challenge outcome
  TD nTD Total   TD nTD Total 
Cu
ltu
re
-P
CR
 re
su
lt PosiƟve 17 6 23 
Bl
oo
d 
cu
ltu
re
 re
su
lt
PosiƟve 21 N/A* 21 
NegaƟve 7 11 18 NegaƟve 3 17 20 
Total 24 17 41 Total 24 17 41 
 Culture-PCR  Blood culture
SensiƟvity 0.70 [0.49 - 0.87]  0.88 [0.67 – 0.97]   
Specificity 0.65 [0.38 – 0.86]  1.00* [0.80 – 1.00]   
LR+ 2.01 [1.00 – 4.01]  N/A    
LR- 0.45    [0.22 – 0.92]  0.12 [0.04 – 0.36]   
PPV 0.74 [0.52 – 0.90]  1.00 [0.84 – 1.00]   
NPV 0.61 [0.36 – 0.83]  0.85 [0.62 – 0.97]   
DOR 4.5 [1.2 – 17.5] 215 [10.4 – 4448]   
364 T.C. Darton et al.Nevertheless, selective culture to release viable bacteria
from the blood intracellular compartment has been shown
to produce an almost 2-fold rise in bacterial numbers.36
While broths containing 10% and more of ox-bile have
been shown to be at best bacteriostatic for S. Typhi growth,
our recent work identified that, at an optimal concentra-
tion of w2.4% and with 5-h incubation, a significant in-
crease in bacterial numbers may be achieved
(Supplementary Table 4).18,19 The addition of micrococcal
nuclease during the extraction process to remove remaining
human DNA further improved assay sensitivity.20
Our identification of participants with asymptomatic
infection, i.e. participants who had evidence of DNA in
the blood (positive culture-PCR result) or bacterial shed-
ding in stool (positive stool culture) in the absence of
fever or clinical signs of infection, may represent false
positive assay results. While various S. Typhi targets have
been used previously, Song and colleagues first described
the use of PCR to detect flagellin sequences in 1993.12
Flagellin expression is monophasic in several Salmonella
sp. including S. Typhi, and the phase-1 antigen ‘d’ is found
in many species. While the end regions of fliC-d (previ-
ously H1-d) are identical between species, there are two
hypervariable regions (IV and VI) unique to S. Typhi and
similar to S. Muenchen.26 Selecting primers targeting
this region should therefore result in good specificity
with little overlap with environmental or other Salmo-
nella species.
Identification of probable asymptomatic, subclinical
typhoid patients has been previously noted in other sus-
ceptible patient groups including the historical typhoid
challenge studies performed in Maryland.37 A study inCambodia, for example, identified a subpopulation among
children <16 years old presenting with fever who were
culture-negative but positive using a real-time PCR assay.38
Of note, this subpopulation was younger, had a shorter
duration of illness prior to presentation and presented
with fewer features characteristic of typhoid infection.
‘Incomplete immunity’ and earlier presentation with illness
are common to both patient/participant groups which may
reflect higher bacterial loads.
The occurrence of a primary, subclinical, bacteraemia
that results in the dissemination of bacteria to the
lymphoreticular system has long been speculated.7,16 While
early studies demonstrated bacteraemia in patients and
challenge study participants as early as 4 or 3 days, respec-
tively,16,37 these cases likely represented early true infec-
tion. Individuals were febrile and went on to develop
overt clinical infection, probably as a result of high expo-
sure dose, which has been shown to correlate to shorter in-
cubation periods.21 Similar results were observed in studies
performed in chimpanzees.39 Our culture-PCR results sug-
gest that S. Typhi DNA is detectable in blood within 48 h af-
ter ingestion; data that are supported by corresponding
increases in plasma cytokines and host gene expression ac-
tivity.40 Factors affecting the outcome of these early inva-
sion events, which probably occur more frequently than
was recognised here as demonstrated by the ubiquitous
cytokine signature found in challenged participants, are un-
certain but probably include the host inflammatory re-
sponses and early immune responses.
There are known limitations to reporting of detecting S.
Typhi DNA from clinical samples, which include the inappro-
priate validation of the methodology, using nested primers
Culture-PCR assay for typhoid 365and use of archived samples rather than a real time com-
parison between culture and PCR technique.13 While some
of these may be overcome by using real-time PCR, these
techniques have reiterated the difficulty of amplifying
very low DNA copy numbers which suggests its continued
inferiority to standard bacterial culture.13 Overreliance on
culture methods as the true reference standard is known
to be problematic,33 however, and therefore corroborating
clinical and stool culture data is also valuable.41
While PCR is a relatively commonly performed technique
in most diagnostic laboratories, including those in less well-
resourced settings, the pre-culture step, which is vital to
increase assay sensitivity, does not yet render the proced-
ure beyond cross-infection (or cross-contamination) risk.
The highly selective nature of ox-bile, while suitable for S.
Typhi and other bile resistant organisms, means that this
assay is of questionable applicability to most settings where
clinical material is scant and S. Typhi is not the predomi-
nant pathogen.6 Alternative lysing agents have been pro-
posed, including saponin (used for bacterial blood
quantification in this study) and digitonin, which may pro-
duce cell lysis without loss of bacterial viability.42,43 In
the specific context of vaccine field or probe studies, how-
ever, such a ‘mono-directional’ assay, possibly with the
additional of targeted S. Paratyphi A primers,44 may offer
additional support to validate efficacy at least in small
scale studies.
An important limitation of our assay was the volume of
blood required to perform the test. While the lower
volumes may be used, the stochastic nature of sampling
such low-density bacteraemic blood will necessarily result
in a reduction in sensitivity. It is also important to note the
difference between blood volumes used in our evaluation:
blood culture was performed with 10 mL whereas the
culture-PCR assay was performed with 5 mL. While detec-
tion of bacteraemia was key to the endpoint for the clinical
study, ethical and physiological limitations to sampling
meant that a matched volume could not be collected at
every time point. This likely underestimates the perfor-
mance of our culture-PCR assay.
In conclusion, a selective culture-PCR assay targeting
the flagellin gene, while less sensitive than optimally
performed blood culture for the detection of participants
developing typhoid infection after challenge, provides
useful additive diagnostic information regarding the
outcome of typhoid challenge. Performing evaluation of
newly available diagnostics in the context of a human
challenge study highlights important features of the natural
history of typhoid infection. These include the frequency of
asymptomatic cases and new evidence for primary bacter-
aemia occurring soon after ingestion.Funding
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